Physician profile
Julia Lederer
NPI 1174282388
$1,884.56
in general payments reported to CMS, 2019-2025
21 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $489 · 2023: $524 · 2024: $418 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,396.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.18 | 2022-2025 | |
| Novo Nordisk INC | $315.62 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $226.85 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $147.53 | 2023-2025 | |
| Exact Sciences Corporation | $118.68 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $116.37 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $115.26 | 2023-2025 | Evenity, Prolia, Otezla |
| Myriad Women'S Health, INC. | $58.57 | 2023 | Myrisk |
| Astellas Pharma US INC | $58.29 | 2024 | Veozah |
| Glaxosmithkline, LLC. | $47.93 | 2022-2025 | Shingrix, Arexvy |
| Abiomed | $36.06 | 2025 | |
| Vanda Pharmaceuticals INC. | $33.22 | 2022 | |
| Coopersurgical, INC. | $26.99 | 2025 | Paragard T 380a |
| Sanofi Pasteur INC. | $26.65 | 2023 | |
| Edwards Lifesciences Corporation | $26.48 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $25.08 | 2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.00 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $23.58 | 2024 | |
| Lucid Diagnostics INC. | $18.94 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.53 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lederer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.